Todd Lanman, MD, of Beverly Hills, Calif.-based Lanman Spinal Neurosurgery on Feb. 24 began enrolling for a clinical trial featuring two artificial cervical discs from Centinel Spine.
The study will compare the prodisc C Vivo and prodisc C SK cervical discs with the Mobi-C, which received FDA approval in 2013.
The two-to-one randomized trial is enrolling patients with neck and arm pain who have not had a previous spine surgery.
The Mobi-C device will be used as a control to determine the safety and efficacy of the trial discs to treat cervical disc disease in patients unresponsive to nonoperative treatment at two levels.